500087.BO - Cipla Limited

BSE - BSE Real Time Price. Currency in INR

Cipla Limited

Cipla House
Peninsula Business Park Ganpatrao Kadam Marg Lower Parel
Mumbai 400013
91 22 2482 6000

IndustryDrug Manufacturers - Major
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Umang Vohra B.E., M.B.A.MD, Global CEO & Director136.6MN/A1971
Mrs. Samina VaziralliExec. Vice Chairman39MN/A1976
Mr. Kedar Upadhye B.Com., AICWA, CS, MBAGlobal Chief Financial Officer31.3MN/A1977
Mr. Raju SubrahmanyamGlobal Head of OperationsN/AN/AN/A
Mr. Rajendra ChopraCompliance Officer & Company Sec.2.4MN/AN/A
Amounts are as of 31 December 2017, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.


Cipla Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India. It offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as women's health, cardiovascular, children's health, dermatology and cosmeceuticals, diabetes, HIV-AIDS, hepatitis, oncology, infectious diseases and critical care, malaria, neurosciences, ophthalmology, osteoporosis, respiratory, and urology. The company also provides veterinary products, including anti-infectives, anti-inflammatories, anti-thyroids, immunosuppressants, parasiticides, nutraceuticals, and feed additives for various animals, including equine and companion care, livestock, poultry, swine, and aqua products. In addition, it offers inhalation therapy devices comprising metered-dose inhalers, dry powder inhalers, nasal sprays, nebulizers, and inhalation accessory devices, as well as spacers and related devices. The company also exports its products to Africa, the Middle East, Latin America, the Asia Pacific, North America, Australia, New Zealand, Russia, and internationally. Cipla Limited was founded in 1935 and is based in Mumbai, India.

Corporate governance

Cipla Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.